Matthias Steffen pitched at Medica 2023

18. Dez.

Verfasst von

FUSE-AI was nominated as one of the 12 finalists for the Startup-Competition, which was pre-selected by Medica from a pool of 260 startups. On November 14, 2023, Matthias Steffen presented Prostate.Carcinoma.ai in light of the global demand for AI-based diagnostic assistance systems and our upcoming market entry.

As part of the Xlife Sciences network, we exhibited alongside three partner companies of Xlife Sciences AG, Switzerland, showcasing the AI-based software Prostate.Carcinoma.ai and other AI-based software solutions for diagnostic applications.

From November 13 to 16, 2023, the 5,372 companies participating in Medica 2023 and the 735 companies represented at Compamed 2023 offered impressive insights into their expertise. Their focus was on realizing modern healthcare solutions in medical practices and clinics, ranging from high-tech supply components to high-performance end products.

Despite the continued leading position of the German medical technology market in Europe, with a volume of around 36 billion Euros, the export rate of the German medical technology industry stands at nearly 70 percent. Prostate.Carcinoma.ai will also be exportable to many countries thanks to MDSAP and FDA 510(k) approvals.

Medica serves as a significant marketplace for the strongly export-oriented German medical technology sector to showcase its offerings to potential customers from around the world.